Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson’s disease: current evidence and future perspectives
Elisa Mantovani, Chiara Zucchella, Andreas A. Argyriou, et al.
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 1, pp. 25-43
Closed Access | Times Cited: 19

Showing 19 citing articles:

Cognitive telerehabilitation: an expert consensus paper on current evidence and future perspective
Maria Grazia Maggio, Francesca Baglio, Francesco Arcuri, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 9
Managing cognitive impairment in Parkinson’s disease: an update of the literature
Jennifer G. Goldman, Priya Jagota, Elie Matar
Expert Review of Neurotherapeutics (2025), pp. 1-21
Closed Access
Association of Favorable Cerebrospinal Fluid Markers With Reversion of Mild Cognitive Impairment Due to Parkinson’s Disease
Cameron A. Ryczek, Rhiannon Rivas, Lea Hemphill, et al.
Journal of Neuropsychiatry (2025)
Closed Access
OLFACTORY DYSFUNCTION: AN EARLY INDICATOR OF PARKINSON'S DISEASE
Dhuly Chowdhury, Ashmita Das, Mrityunjay Mishra, et al.
Brain Disorders (2025), pp. 100209-100209
Open Access
Pathological Correlates of Cognitive Decline in Parkinson’s Disease: From Molecules to Neural Networks
Н Ю Новиков, E. S. Brazhnik, Valentina Kitchigina
Biochemistry (Moscow) (2023) Vol. 88, Iss. 11, pp. 1890-1904
Closed Access | Times Cited: 11
Towards multimodal cognition-based treatment for cognitive impairment in Parkinson's disease: drugs, exercise, non-invasive brain stimulation and technologies
Elisa Mantovani, Miriana Maria Bressan, Michèle Tinazzi, et al.
Current Opinion in Neurology (2024) Vol. 37, Iss. 6, pp. 629-637
Closed Access | Times Cited: 2
TMS and tDCS as potential tools for the treatment of cognitive deficits in Parkinson’s disease: a meta-analysis
Andreina Giustiniani, Lorenza Maistrello, Valentina Mologni, et al.
Neurological Sciences (2024)
Closed Access | Times Cited: 2
Improving Functional Capacity and Quality of Life in Parkinson’s Disease Patients through REAC Neuromodulation Treatments for Mood and Behavioral Disorders
Chiara Rinaldi, Cleuton Braga Landre, MARIA IZABEL T.C. VOLPE, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 6, pp. 937-937
Open Access | Times Cited: 5
Ribose-cysteine and levodopa abrogate Parkinsonism via the regulation of neurochemical and redox activities in alpha-synuclein transgenic Drosophila melanogaster models
Olumayowa K. Idowu, A.A. Oremosu, O.O. Dosumu, et al.
Fly (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Biomarkers for cognitive impairment in alpha-synucleinopathies: an overview of systematic reviews and meta-analyses
Elisa Mantovani, Alice Martini, Alessandro Dinoto, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Pathological correlates of cognitive decline in Parkinson’s disease: from molecules to neural networks
Н Ю Новиков, E. S. Brazhnik, В. Ф. Кичигина
Биохимия (2023) Vol. 88, Iss. 11, pp. 2289-2307
Closed Access | Times Cited: 3
Psychosis in Parkinson’s Disease and Current Management Trends- an Updated Review of Literature
Rajib Dutta
Journal of Neuroscience and Neurological Disorders (2023) Vol. 7, Iss. 2, pp. 027-057
Open Access | Times Cited: 2
Brain Stimulation Techniques in Research and Clinical Practice: A Comprehensive Review of Applications and Therapeutic Potential in Parkinson’s Disease
Ata Jahangir Moshayedi, Tahmineh Mokhtari, Mehran Emadi Andani
Brain Sciences (2024) Vol. 15, Iss. 1, pp. 20-20
Open Access
Customized treatment for Parkinson’s disease: extending lifespan and improving symptoms
Richa Indu, Sushil Chandra Dimri
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2024) Vol. 60, Iss. 1
Open Access
Evaluation of Neuroprotective Effect of Gut Microbe in Parkinson's Disease: An In Silico and In Vivo Approach
Kanika Bhardwaj, Neelu Kanwar Rajawat, Nupur Mathur, et al.
NeuroMolecular Medicine (2024) Vol. 26, Iss. 1
Closed Access
Treatment of Parkinson’s Disease Psychosis—A Systematic Review and Multi-Methods Approach
Olaf Rose, S. J. Huber, Eugen Trinka, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2317-2317
Open Access
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation
Stefano Tamburin
Current Opinion in Neurology (2024) Vol. 37, Iss. 6, pp. 611-613
Closed Access
Psychiatric Disorders and Cognitive Fluctuations in Parkinson’s Disease: Changing Approaches in the First Decades of the 21st Century
Marco Onofrj, Matteo Alessandro De Rosa, Mirella Russo, et al.
Brain Sciences (2024) Vol. 14, Iss. 12, pp. 1233-1233
Open Access
Future Directions for Developing Non-dopaminergic Strategies for the Treatment of Parkinson’s Disease
Daniel J. van Wamelen, Valentina Leta, К. Ray Chaudhuri, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 10, pp. 1606-1620
Closed Access
Page 1

Scroll to top